Donald Trump is reportedly expected to claim there is a link between the use of paracetamol in pregnancy and the development of autism - but what does the evidence say?Americans consume more than 40% of all the world's paracetamol, spending in excess of $4bn a year on products containing acetaminophen (as it is known in America - or by its leading brand name, Tylenol). Autism rates in the US are also on the rise - going up from about one in 150 children in the year 2000, to around one in 30 today.There have ...

Kenvue's stock was heading for a record low as investors express concerns over what President Trump will say regarding the use of acetaminophen — the active ingredient in Tylenol — and the autism epid... ...

Shares of Kenvue, the consumer-health spinoff of Johnson & Johnson, tumbled 7.1% to a record low of $17.03 on Monday with the selloff coming ahead of US President Donald Trump's planned announcement t... ...

Welcome back to Money Movers. Take a look at Tylenol maker Ken View. Down over 7% at record lows now following reports that the Trump administration is planning to link Tylenol to autism risk during pregnancy.A Ken View spokesperson telling CNBC in part, quote, "We believe independent sound science clearly shows that taking acetamophen does not cause autism." President Trump is scheduled to make remarks on quote significant medical and scientific findings for America's children at 400 pm Eastern time today. ...

Qilai Shen / Bloomberg / Getty Images Nvidia shares climbed after the chipmaker announced a $100 billion investment in ChatGPT maker OpenAI. Key Takeaways Major U.S. equities indexes climbed Monday afternoon, boosted by gains in the tech sector as Nvidia announced a big investment in ChatGPT maker OpenAI. Apple shares rose after Wedbush raised its price target for the stock, pointing to better-than-expected demand for the iPhone 17. Kenvue shares slumped following reports the Trump administration wil ...

President Donald Trump is expected to give a Monday afternoon announcement linking the use of popular over-the-counter pain medication Tylenol to the development of autism during pregnancy, a claim wh... ...

Shares of Tylenol maker Kenvue (KVUE) are dropping in morning trading on a report that the White House is expected to make an announcement Monday linking pregnant women's use of the painkiller to increased risk of autism. ...

Tylenol maker Kenvue 'strongly disagrees' there is a causal link between acetaminophen use during pregnancy and autism. ...

About this content About Ian Lyall Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive's editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually. Prior to Proactive, Ian helped lead the business outpu ...

Kenvue Inc. (NYSE:KVUE) is one of the stocks Jim Cramer recently gave takes on. When a caller mentioned the company’s litigation risk, Cramer commented: “I don’t think the litigation risk is nearly as bad as people think. This stock is at 4.5%. It’s got new leadership. I don’t want to dump it right here. I just don’t, but I don’t expect a lot of upside here. That’s the problem.” A laptop and a computer monitor display a detailed stock market technical analysis chart. Photo by Jakub Zerdzicki on Pexels ...